Atlas Trials

Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's Disease

Clinical trial NCT00471211 · COMPLETED

Trial details

NCT number
NCT00471211
Sponsor
Prana Biotechnology Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2006-12-01
Primary completion
2007-12-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.